Login to your account

Username *
Password *
Remember Me
RCT | P2Y12 inhibitors don’t improve outcomes in critically ill COVID-19 patients

RCT | P2Y12 inhibitors don’t improve outcomes in critically ill COVID-19 patients

Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial – JAMA Network Open See also: Visual Abstract  

The post RCT | P2Y12 inhibitors don’t improve outcomes in critically ill COVID-19 patients appeared first on Links Medicus.

Lu 56 fois
Évaluer cet élément
(0 Votes)

About Author

Laissez un commentaire

Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.